Glaukos (GKOS) Competitors $99.25 +3.61 (+3.77%) Closing price 03:59 PM EasternExtended Trading$100.28 +1.03 (+1.04%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GKOS vs. PHG, ZBH, SNN, SOLV, PEN, STVN, NARI, IRTC, TMDX, and BLCOShould you be buying Glaukos stock or one of its competitors? The main competitors of Glaukos include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry. Glaukos vs. Koninklijke Philips Zimmer Biomet Smith & Nephew Solventum Penumbra Stevanato Group Inari Medical iRhythm Technologies TransMedics Group Bausch + Lomb Glaukos (NYSE:GKOS) and Koninklijke Philips (NYSE:PHG) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk, institutional ownership and community ranking. Which has stronger valuation & earnings, GKOS or PHG? Glaukos has higher earnings, but lower revenue than Koninklijke Philips. Glaukos is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlaukos$404.52M13.52-$134.66M-$2.37-40.37Koninklijke Philips$17.98B1.25-$503.27M$0.4355.43 Do institutionals and insiders believe in GKOS or PHG? 99.0% of Glaukos shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 5.8% of Glaukos shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer GKOS or PHG? In the previous week, Koninklijke Philips had 4 more articles in the media than Glaukos. MarketBeat recorded 8 mentions for Koninklijke Philips and 4 mentions for Glaukos. Glaukos' average media sentiment score of 0.56 beat Koninklijke Philips' score of 0.31 indicating that Glaukos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, GKOS or PHG? Glaukos has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, Koninklijke Philips has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Is GKOS or PHG more profitable? Koninklijke Philips has a net margin of -3.88% compared to Glaukos' net margin of -39.04%. Koninklijke Philips' return on equity of 10.85% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Glaukos-39.04% -16.53% -10.61% Koninklijke Philips -3.88%10.85%4.45% Does the MarketBeat Community favor GKOS or PHG? Glaukos received 76 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 65.19% of users gave Glaukos an outperform vote while only 56.70% of users gave Koninklijke Philips an outperform vote. CompanyUnderperformOutperformGlaukosOutperform Votes45765.19% Underperform Votes24434.81% Koninklijke PhilipsOutperform Votes38156.70% Underperform Votes29143.30% Do analysts recommend GKOS or PHG? Glaukos currently has a consensus price target of $134.67, suggesting a potential upside of 40.75%. Given Glaukos' higher possible upside, research analysts plainly believe Glaukos is more favorable than Koninklijke Philips.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glaukos 1 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.75Koninklijke Philips 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryGlaukos beats Koninklijke Philips on 10 of the 19 factors compared between the two stocks. Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GKOS vs. The Competition Export to ExcelMetricGlaukosSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$5.47B$4.38B$5.55B$19.79BDividend YieldN/A42.67%5.27%3.84%P/E Ratio-33.3428.2027.2335.71Price / Sales13.5270.27423.1845.94Price / CashN/A51.0838.2517.52Price / Book10.115.967.124.84Net Income-$134.66M$67.01M$3.23B$1.02B7 Day Performance5.15%1.53%3.78%2.29%1 Month Performance6.38%18.46%13.33%5.86%1 Year Performance-15.46%19.19%32.07%11.14% Glaukos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GKOSGlaukos4.5692 of 5 stars$99.25+3.8%$134.67+35.7%-15.2%$5.67B$404.52M-34.58780Positive NewsPHGKoninklijke Philips2.6289 of 5 stars$22.81-1.0%N/A-9.3%$21.44B$17.98B-27.1578,200ZBHZimmer Biomet4.8544 of 5 stars$91.12-1.1%$111.53+22.4%-16.0%$18.03B$7.70B20.4818,000Positive NewsSNNSmith & Nephew2.338 of 5 stars$29.17+0.7%$28.00-4.0%+15.0%$12.78B$5.81B13.5120,100Short Interest ↑SOLVSolventum0.2777 of 5 stars$73.080.0%$80.29+9.9%+33.1%$12.64B$8.31B33.8322,000Positive NewsPENPenumbra4.5694 of 5 stars$256.57-3.9%$302.40+17.9%+35.8%$9.94B$1.24B754.623,900STVNStevanato Group1.5457 of 5 stars€22.01-0.9%N/A+32.9%$6.67B$1.12B46.834,650Positive NewsNARIInari Medical0.2471 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageIRTCiRhythm Technologies1.1969 of 5 stars$140.65+0.1%$133.73-4.9%+56.1%$4.49B$618.59M-38.641,790Analyst ForecastTMDXTransMedics Group1.4554 of 5 stars$123.94-2.5%$126.70+2.2%-2.6%$4.19B$488.23M131.85210BLCOBausch + Lomb3.6826 of 5 stars$11.46-0.1%$15.50+35.3%-16.2%$4.05B$4.83B-12.5912,500Analyst Forecast Related Companies and Tools Related Companies PHG Alternatives ZBH Alternatives SNN Alternatives SOLV Alternatives PEN Alternatives STVN Alternatives NARI Alternatives IRTC Alternatives TMDX Alternatives BLCO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GKOS) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glaukos Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Glaukos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.